Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (MIBC) (AMBASSADOR) vs Observation
- Citation:
- J Clin Oncol vol 37 (suppl 7S) abstr TPS504
- Meeting Instance:
- ASCO GU 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, Merck
- Corr. Author:
- Authors:
- Andrea Apolo Jonathan Rosenberg Michael Morris Karla Ballman Bishoy Faltas Ronald Chen Marissa Mallek Colleen Watt William Kim Sandy Srinivasan Guru Sonpavde
- Networks:
- FL086, KANSAS, LAPS-NC007, LAPS-NY016, MD001, NY018
- Study
- Alliance-A031501
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: